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ABSTRACT 1 
 2 
Objective: To show that subjective estimate of patient’s condition is related to objective 3 
cognitive and functional outcome in cardiac arrest survivors.  4 
Design: Longitudinal cohort study.  5 
Setting: Intensive Care Unit (ICU) and Neuropsychology Service, Lausanne University Hospital 6 
and Valais Hospital, Switzerland.  7 
Patients: 50 survivors were included from a prospective cohort of 138 patients admitted at the 8 
ICU for cardio-pulmonary arrest. 9 
Interventions: Comprehensive cognitive and functional evaluation at 6 months follow-up.  10 
Measurements and Main Results: Subjectively, 70% of survivors reported that they returned to 11 
their pre-injury functioning and 29% reported no complaints. Objectively, 76% were classified as 12 
good neurological outcome (Cerebral Performance Category 1), 26% as having no symptoms 13 
(modified Rankin Scale 0) and 38% as upper good recovery (GOSE 1). Cognitive assessment 14 
detected substantial cognitive impairment in 26%, primarily concerning processing speed, 15 
language, long-term memory and executive functions. Subjective complaints severity correlated 16 
significantly with objective cognitive impairment (rS=0.64, p<0.001). Finally, patients reporting 17 
unsatisfactory recovery displayed lower functional scores than those reporting satisfactory 18 
recovery (e.g. quality of life satisfaction: 64% vs. 79%; Z=2.18, p=0.03) and more cognitive 19 
impairment (3 (2-4.5) vs. 1 (0-3) cognitive domains impaired; Z = -3.21, p < 0.001), concerning 20 
in particular learning and long-term verbal and visual memory.  21 
Conclusions: Long-term subjective and objective outcome appears good in the majority of CA 22 
survivors. Specific functional and cognitive impairments were found in patients reporting 23 
unsatisfactory recovery. Subjective recovery seems to was strongly correlate with objective 24 
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measures. 1 
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INTRODUCTION 1 
 2 
Cardiac arrest (CA) represents the leading cause of death, with at most 11% of patients surviving 3 
hospital discharge (1). Among these, neurological recovery is usually good, with 85% classified 4 
as Cerebral Performance Category (CPC) (2) 1 or 2 (3). However, previous studies reported 5 
some degree of long-term cognitive dysfunction in about 50% of survivors (4–6), particularly in 6 
memory, attention, and executive functioning(6–10). Compared to control subjects with 7 
myocardial infarction, CA survivors are more frequently impaired in attention and mental speed, 8 
while memory and executive functions seem similar (6). Long-term functional impairment in CA 9 
survivors has also been described in several studies: up to 50% of patients report severe fatigue 10 
(11), 18% need help with everyday activities (12), and 24% report anxiety, though in similar 11 
proportion to controls (13). Altered quality of life has also been noted, particularly in survivors 12 
with CPC 2 or 3 (14).  13 
Interestingly, patients’ subjective perception of their recovery has rarely been addressed, though 14 
subjective perception of well-being is the ultimate aim of any clinical intervention. In addition, 15 
how subjective evaluation is related to objective measures is even less clear. Significant 16 
complaints have been found in 14% of survivors, but these were not associated with cognition 17 
(15). In contrast, complete subjective recovery has been reported in 62-66% of survivors (12) 18 
and correlated with anxiety and depression symptoms (13).  19 
Here we present the results of an exhaustive cognitive and functional evaluation, including 20 
subjective measures, at six months follow-up. In addition to describing overall outcome, we 21 
hypothesized that subjective perception of recovery constitutes a reliable surrogate for detailed 22 
objective assessment of patients’ cognitive and functional status. In particular, we postulated that 23 
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patients who report a satisfactory recovery would show better results in standard objective 1 
measures.  2 
 3 
4 
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MATERIAL AND METHODS 1 
 2 
Study design and population 3 
We prospectively considered all adult comatose patients admitted after CA to the 4 
interdisciplinary ICU between July 2012 and May 2015 at the Lausanne University Hospital, and 5 
between June 2014 and May 2015 at the Valais Hospital. All patients were treated using a 6 
standardized protocol (16, 17). Decision to withdraw intensive care was based on early 7 
multimodal assessment performed during the first days of coma (see Suppl. Doc 1 for further 8 
description). This study received full approval from both local Ethics Commissions. Informed 9 
consent was obtained on admission, from a family member or a physician not involved in the 10 
study, and at follow-up, from the patient or a family member. Six months after CA, patients with 11 
no prior severe neurologic or psychiatric conditions were offered functional and cognitive 12 
assessment.  13 
 14 
Subjective and objective functional outcome assessment 15 
Functional outcome was evaluated 6 months after CA by EJ, through a semi-structured phone 16 
interview or in person, prior to the neuropsychological assessment (in order to limit the influence 17 
of the upcoming cognitive evaluation). Global outcome was assessed both subjectively and 18 
objectively. Subjective outcome measures included perception of recovery (“Do you feel that 19 
you are back to your baseline functioning, before the cardiac arrest?”)—used to classify patients 20 
as “satisfactory recovery” for a “yes” answer, or “unsatisfactory recovery” for a “no” answer—21 
and severity of patients’ reported complaints, from 0 (no complaints, spontaneously or upon 22 
questioning) to 4 (severe complaints). Objective outcome measures included Cerebral 23 
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Performance Category (CPC), ranging from 1 (good) to 5 (death) (2), the Modified Rankin scale 1 
(mRS), ranging from 0 (no symptoms) to 6 (death) (18), and the French version of the Glasgow 2 
Outcome Scale Extended (GOSE), ranging from 1 (upper good recovery) to 8 (death) (19).  3 
Complementing these global rating scales, we also assessed specific functional aspects: 4 
complaints systematically prompted by questions for eight domains (language, gnosia, praxia, 5 
memory, attention, fatigue, behavior or emotional changes, slowing), the Quality of Life after 6 
Brain Injury scale (QOLIBRI) (20), anxiety and depression (Hospital Anxiety and Depression 7 
scale, HAD) (21, 22), independence in daily activities (Instrumental Activities of Daily Living 8 
scale, IADL) (23), professional activity and driving resumption.  9 
 10 
Cognitive outcome assessment 11 
This was assessed at 6 months by a standard neuropsychological evaluation lasting 2.5 h 12 
performed by the same certified neuropsychologist (EJ) in the outpatient consultation. Thirteen 13 
scores were extracted to characterize representative cognitive domains: the naming subtest of the 14 
Lexis battery (language) (24), the French version of the California Verbal Learning Test 15 
(learning and long-term verbal memory) (25), the Doors and People test (long-term visual 16 
memory) (26), WAIS-IV digit span forward subtest (short-term verbal memory) (27), MEM-III 17 
block tapping forward subtest (short-term visual memory) (28), the Five-points test 18 
(productivity) (29), WAIS-IV digit-symbol subtest (processing speed) (27), and the alert and 19 
divided attention subtests of the Test battery for Attentional Performance (resp. reaction times 20 
and divided attention) (TAP) (30). Initiation, Inhibition and Generation scores were calculated 21 
following a method proposed by Godefroy (31) using semantic and phonemic verbal fluency, 22 
Trail Making and Stroop tests from the GREFEX battery (18) (see Suppl. Doc2 for details). Raw 23 
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scores were corrected for age and socio-cultural level according to published norms, and 1 
transformed into standard z-scores. The cut-off for impaired performance was a z-score ≤ –1.65 2 
SD of published norms. An individual global cognitive impairment index (GCI) was calculated 3 
as the number of tests impaired. Patients with three or more domains impaired (≥23% of the test 4 
battery) were considered to have substantial cognitive impairment. 5 
 6 
Comparing subjective vs. objective recovery  7 
Spearman’s rank correlations tested associations between subjective and objective global 8 
functional outcome measures; performance of subjective measures to identify objectively good 9 
outcomes, defined as CPC 1, was addressed with a 2x2 table (using exact binomial confidence 10 
intervals). 11 
To address whether subjective assessment is informative about detailed objective outcomes, we 12 
tested whether patients reporting “satisfactory recovery” differed from those with “unsatisfactory 13 
recovery” in several cognitive and functional domains, using two-sided non-parametric tests for 14 
continuous variables (Wilcoxon signed rank test) or Fisher exact tests for categorical variables. 15 
Finally, to determine whether subjective perception of cognitive status accurately reflects actual 16 
cognitive performance, we correlated complaints severity with GCI. 17 
Descriptive statistics are given as median (range), unless otherwise specified. The significance 18 
level was set at 2-sided α = 0.05. We did not correct for multiple comparisons, given the 19 
exploratory nature of this study. All analyses were run on MATLAB 2015b. 20 
21 
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RESULTS 1 
 2 
Population 3 
Over the study period, 138 post-CA comatose patients were admitted (Lausanne: 121, Valais: 4 
17). Among them, 67 were discharged (49% survival). Six months after CA (29 ± 3 weeks), 50 5 
(Lausanne: 48, Valais: 2; see Table 1) received long-term assessment, and 42 also undergo 6 
neuropsychological testing (Fig.1).   7 
Main reasons for non-inclusion were patient’s refusal (n = 7), severe pre-existing neurologic or 8 
psychiatric comorbidities (n = 5), and patients living too far from the assessment center or being 9 
otherwise impossible to reach (n = 4). The 17 non-included survivors (59 (48–78) years old, 5 10 
women (29%)) did not differ in demographics, but exhibited worse CPC at 3 months (2 (1-3) vs. 11 
1 (1-2); Z = 2.32, p = 0.02).  12 
 13 
Functional outcome 14 
At 6 months follow-up, all but one patient had returned home . Subjective measures showed that 15 
35 (70%) reported a satisfactory recovery, 14 (29%) with no complaint. Objective measures 16 
classified 38 (76%) as CPC 1, 13 (26%) as mRS 0, and 19 (38%) as GOSE 1 (see Fig. 2). 17 
Subjective and objective outcome measures were strongly and positively correlated (CPC and 18 
subjective recovery: rs = 0.56, p < 0.001; mRS and complaints severity: rs = 0.53, p < 0.001; see 19 
Fig. 2). Performances of subjective recovery in identifying patients with objective good 20 
outcomes (CPC 1) were: sensitivity 0.84 (95% CI: 0.73–0.96), specificity 0.75 (95% CI: 0.51–21 
0.99), positive predictive value (PPV) 0.91 (95%CI: 0.82-1.00). 22 
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Fatigue was the most frequently reported complaint (35/49 patients (one patient was unable to 1 
respond); 71%), followed by change in behavior or emotion (25; 51%), slowing (24; 49%), 2 
attention (18; 37%), memory (17; 35%), language (12; 24%). Gnosia or praxia impairment were 3 
rare (1; 2%). The majority of patients were independent for daily activities (IADL > 6 points: 4 
42/50; 84%); 16/26 (61%) were able to resume working and 29/40 (73%) could resume driving. 5 
Five patients (10%) showed signs of anxiety and 3 (6%) of depression (HAD). Overall quality of 6 
life satisfaction was 75 ± 17%.  7 
Regarding subjective outcome, those reporting “unsatisfactory recovery” showed significantly 8 
worse results on all global objective and subjective outcome scales (Table 2). They also reported 9 
lower quality of life satisfaction (total QOLIBRI score, physical problem score, and to a lesser 10 
extent emotional and cognitive scores), more frequent complaints (memory, attention, slowing, 11 
fatigue), depression symptoms (HAD), and impairment of daily living activities (IADL); they 12 
were less likely to return working or resume driving.  13 
 14 
Cognitive outcome 15 
Forty-two patients (30 “satisfactory recovery”, 12 “unsatisfactory recovery”) underwent 16 
neuropsychological examination (seven refused to participate, one was too severely impaired; 17 
CPC at 6 months: 1.5 (1-2) vs. 1 (1-2) in the participating group; Z = 1.98, p = 0.05). Domains 18 
most frequently impaired were processing speed (9 patients impaired; 21%), language (9; 21%), 19 
long-term memory (8; 19%) and initiation (8; 19%). In contrast, domains most often preserved 20 
were short-term verbal memory (2 patients impaired; 5%), reaction times (2; 5%), generation (3; 21 
7%) and productivity (3; 7%) (see Suppl. Doc 2). Overall, patients had 1 (0–3) impaired 22 
cognitive domains (GCI) and 11 (26%) were considered to have substantial impairment. 23 
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Patients with “unsatisfactory recovery” showed significantly worse performance in 7 out of the 1 
13 (54%) cognitive dimensions considered: learning, verbal and visual long-term memory, short-2 
term visual memory, initiation, processing speed, and divided attention (see Fig. 3, Suppl. Doc 3 
2). GCI was also significantly higher in the group “unsatisfactory recovery” (3 (2–4.5) impaired 4 
domains) vs. “satisfactory recovery” (1 (0–3) impaired domains; Z = –3.21, p < 0.001) with 5 
respectively 7 patients (58%) and 4 (13%) having substantial cognitive impairment.   6 
Finally, objective measures of cognitive performance correlated strongly and positively with 7 
subjectively perceived cognitive status (GCI and complaint severity: rS = 0.64, p < 0.001). 8 
 9 
 10 
  11 
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DISCUSSION 1 
 2 
This study shows that subjective evaluation appears to be a reliable indicator of cognitive and 3 
functional long-term outcome in CA survivors. In fact, 70% of patients deemed they had 4 
returned to pre-injury functioning level, while objective evaluation identified 76% as CPC 1. 5 
Subjective assessment had high sensitivity and PPV in identifying CPC 1. Subjective measures 6 
correlated strongly with all objective global outcome scales and objective evaluation of cognitive 7 
impairment. Grouping patients by subjective outcome assessment, we showed that survivors 8 
reporting satisfactory recovery exhibit consistently better results than those with unsatisfactory 9 
recovery on specific functional dimensions, including quality of life, domains of complaints, 10 
independence, depression, ability to return to work and resume driving. They also displayed 11 
better cognitive performance in most of the cognitive domains tested, particularly learning, long-12 
term memory, and selected dimensions of attention and executive functions.  13 
 14 
As a whole, our sample of CA survivors experienced good overall long-term outcomes, 15 
consistent with previous literature reporting CPC 1 in 84% (8) and complete subjective mental 16 
recovery in 62 to 66% (12). However, as highlighted in previous reports (4), detailed evaluation 17 
tempers these proportions: our patients had frequent complaints, especially concerning fatigue 18 
(71%) and being unable to go back to work (39%). In contrast, quality of life satisfaction was 19 
high (75%, similar to 76% previously reported at a more distant follow-up time (32)) and anxiety 20 
and depressive symptoms were rare (10% and 6% respectively, similar to the findings of 11% 21 
and 7% in (13)). Detailed neuropsychological evaluation detected substantial cognitive 22 
impairment in 26% of survivors, higher than the 13% at 3 months or 11% at one year reported in 23 
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(15) (potentially explained by the higher number of tests considered in our study, 13 vs. 6), but 1 
lower than the 50% of patients showing mild cognitive impairment reported in (6). In particular, 2 
we revealed that impairment in processing speed (21%) and language (21%) were as frequent as 3 
the classical impairments in long-term verbal memory (19%) or executive functions (19% for 4 
initiation, 17% for inhibition) (6, 15).  5 
 6 
Long-term memory complaints have been previously associated with general physical and 7 
mental health (33), while the only study directly testing the association between subjective and 8 
objective measures reported null results (15), using a complex questionnaire (34) to assess 9 
subjective outcome, rendering comparison with our binary measure difficult. Our subjective 10 
recovery measure seems more similar to item 2 of the Two Simple Questions (35):  “Do you feel 11 
that you have made a complete mental recovery after your heart arrest?”, leading to a  similar 12 
proportion of patients reporting complete recovery (12), and an association with anxiety and 13 
depression symptoms (13). 14 
 15 
Our results appear consistent with previous studies with larger sample sizes, both on global 16 
functional scales and specific functional and cognitive dimensions (6, 8, 12, 13, 15, 32), 17 
suggesting that these may be generalizable. Furthermore, we report a rigorous cognitive 18 
evaluation, unveiling the importance of processing speed and language impairment in CA 19 
survivors, in addition to the classically demonstrated impairments in memory and executive 20 
functions. Finally, the novel combination of such a detailed evaluation with simple subjective 21 
assessment measures showed a strong association between subjective and objective recovery in 22 
CA survivors. 23 
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This study has some limitations. First, excluded survivors had worse CPC scores at 3 months, 1 
which might indicate a selection bias. However, many excluded survivors had pre-existing 2 
psychiatric or neurologic conditions, which might explain their mitigate outcomes. Therefore, 3 
especially our cognitive results, are applicable only to healthy patients prior to CA and are able 4 
to undergo a prolonged neuropsychological evaluation. Second, grouping patients by subjective 5 
reports may have shortcomings: self-evaluation is modulated by the ability to assess one’s own 6 
condition, i.e. nosognosia, which is also influenced by mood disorders (36). It is therefore 7 
possible that some patients reporting satisfactory recovery minimized their impairment, while 8 
some in the “unsatisfactory recovery” group were influenced by depression (37). However, since 9 
subjective reports correlated strongly with several objective measures, this seems unlikely. Third, 10 
considering that some of the “objective” data are nevertheless based on patient’s responses, 11 
subjective and objective measures are likely not fully independent. This seems a common issue, 12 
and obtaining consistent results in this context reinforces internal validity (32). Fourth, the same 13 
neuropsychologist conducted assessments of subjective and objective measures; we do not 14 
believe that this introduced an information bias, since the CPC at 3 months collected by a 15 
blinded research nurse showed consistent results with other functional data, functional outcome 16 
was obtained before cognitive testing, and most functional measures did not include 17 
neuropsychologist’s involvment (i.e. self-administered questionnaires). Fifth, including a control 18 
group in the study would have allowed estimating the specific impact of CA. However, the tests’ 19 
published norms provide a reliable appreciation of performances. Finally, we lack information on 20 
pre-morbid functional conditions, as in other major studies on this topic (6, 12, 15); however, 21 
subjective assessment provides an indirect evaluation of patient’s premorbid status as it refers to 22 
baseline functioning. 23 
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 1 
 2 
 3 
CONCLUSIONS 4 
 5 
To the best of our knowledge, this work constitutes the first attempt to investigate the association 6 
between patients’ subjective perception of recovery and detailed quantitative assessment, 7 
providing a simple measure of patients’ evaluation taking into account premorbid level of 8 
functioning. In addition, subjective measures correlate significantly with objective cognitive and 9 
functional assessments. Therefore, if confirmed in other settings, this approach could yield new 10 
insight regarding functional follow-up and appropriate calibration of rehabilitation efforts.  11 
  12 
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FIGURES LEGENDS 1 
 2 
Fig.1: Flow of post-anoxic comatose survivors included in the study. The last four boxes 3 
represent the included population: 50 patients were included in the functional assessment (35 4 
“complete recovery” and 15 “incomplete recovery”) and 42 also participated to the 5 
neuropsychological assessment (30 “complete recovery” and 12 “incomplete recovery”).  6 
 7 
Fig.2: Results of subjective (S) and objective (O) global outcome scales. Best scores (e.g. 8 
complete subjective recovery, CPC1, mRS 0) are in white on the left side of the graph, while 9 
worst scores are in dark on the right side, with number of patients for each category in 10 
corresponding bins. Thirty-five survivors (70%) reported complete subjective recovery (in white) 11 
and 15 (30%) incomplete recovery (in grey). Scores ranged from 0 to 4 for Complaints severity 12 
(n=49), 1 to 3 for CPC, 0 to 4 for mRS and 1 to 6 for GOSE. Stars show significant correlations 13 
between Subjective recovery and CPC (rs = 0.56, p < 0.001) and between Complaints severity 14 
and mRS (rs = 0.53, p < 0.001) (see Suppl. Figure 2 for full correlation table). 15 
 16 
Fig.3: Cognitive performance (mean and SD of standard z scores) for 13 cognitive domains by 17 
subjective recovery group (“returned to pre-injury functioning in grey, “not returned to pre-18 
injury functioning” in black). The mean of the reference population (as obtained from published 19 
norms) is a z-score of 0; positive values indicate a score above the norms, i.e. better performance 20 
than the reference population, while negative values indicate a score below, i.e. worse 21 
performance. Significant differences between the two subjective recovery groups are reported in 22 
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parenthesis (* p < 0.05; ** p < 0.01). See supplementary Table 1 for an exhaustive description of 1 
raw scores, z scores and statistical results. 2 
 3 
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SUPPLEMENTARY DATA 1 
 2 
 3 
Doc 1: Description of all cognitive tests used in the neuropsychological assessment.  4 
 5 
Table 1: Results of all neuropsychological tests. 6 
 7 
Table 2: Results to the early clinical variables by recovery group.  8 
 9 
 10 
 11 
 Table 1. Results of clinical tests performed during coma of patients stratified according to their 
subjective recovery at 6 months. 
Continuous variables are presented as median and interquartile and statistically tested with Wilcoxon signed 
rank test. Categorical variables are presented as number (and percentage) and analyzed with Fisher exact test 
(no Z value). Shockable rhythms include ventricular fibrillation and ventricular tachycardia and exclude 
asystolia and pulseless electrical activity. IQR interquartile range; ROSC return of spontaneous circulation.  
 
Clinical tests Survivors reporting 
satisfactory 
recovery  
(n = 35) 
Survivors reporting 
unsatisfactory 
recovery 
(n = 15) 
p value  
(Z value) 
All patients 
(n=50) 
Socio-demographics     
Age, median (IQR), years 61 (53-72) 56 (46-72) 0.6 (0.57)  60 (49-72) 
Female gender, n (%) 7 (20) 6 (40) 0.2  13 (26) 
Cardiac arrest variables     
Cardiac etiology, n (%) 30 (86) 13 (87) 1 43 (86) 
Out-of-hospital CA, n (%) 32 (91) 15 (100) 0.5 47 (94) 
First rhythm shockable, n (%) 30 (86) 10 (67) 0.1 40 (80) 
Time to ROSC, median (IQR), min 15 (10-21) 15 (10-31) 0.4 (0.9) 15 (10-22) 
Hypothermic treatment 35 (100) 13 (87) 0.09 48 (96) 
Juan et al.  
 
Table 1. Long-term functional outcome results by subjective recovery group.  
Functional measure Survivors reporting 
satisfactory recovery 
(n = 35) 
Survivors reporting 
unsatisfactory recovery 
(n = 15) 
p value  
(Z value) 
All survivors 
(n=50) 
Global scales, median (IQR)     
CPC (6 months) 1 (1-2) 2 (1-3) <0.001 (-3.88) ** 1 (1-2) 
CPC (3 months) 1 (1-2) 2 (1-3) <0.001 (3.97) ** 1 (1-2) 
mRS 1 (0-2) 2 (1-3) <0.001 (-4.21) ** 1 (0-2) 
GOSE  1 (1-2)  4 (3-6) <0.001 (-4.78) ** 2 (1-4) 
Complaints severity § 1 (0-2) 3 (1.5-4) <0.001 (-4.64) ** 0 (1-2) 
Quality of life, median (IQR)     
QOLIBRI total § 81 (72-86) 64 (45-86) 0.03 (2.18) * 79 (63-86) 
QOLIBRI cognition § 86 (75-96) 59 (32-93) 0.06 (1.88) 82 (64-96) 
QOLIBRI self § 79 (64-89) 63 (53-86) 0.09 (1.71) 75 (61-86) 
QOLIBRI daily life & autonomy § 86 (64-96) 61 (50-93) 0.09 (1.68) 79 (61-95) 
QOLIBRI social relationships § 79 (73-92) 73 (58-88) 0.10 (1.53) 79 (71-90) 
QOLIBRI emotions § 90 (60-95) 68 (55-80) 0.05 (1.96) 85 (60-95) 
QOLIBRI physical problems § 85 (70-95) 68 (55-80) 0.008 (2.66) ** 85 (65-95) 
Domain of complaints, n (%)     
Memory § 7 (20) 10 (71) 0.002 ** 17 (35) 
Language § 6 (17) 6 (43) 0.08 12 (25) 
Gnosia § 0 (0) 1 (7) 0.29 1 (2) 
Praxia § 0 (0) 0 (0) 1.00 0 (0) 
Attention § 8 (23) 10 (71) 0.003 ** 18 (37) 
Slowing § 13 (37) 11 (79) 0.01 * 24 (49) 
Fatigue § 21 (60) 14 (100) 0.004 ** 35 (71) 
Behavioral/emotional change § 17 (48) 8 (57) 0.75 25 (49) 
Mood disorders, median (IQR)     
HAD anxiety, n impaired § 4 (3-8), 2 8 (4-11), 3 0.07 (-1.84)  6 (3-9), 5 
HAD depression, n impaired § 2 (1-4), 0 5.5 (3-9), 3 0.004 (-2.87) ** 3 (1-5), 3 
Daily living     
IADL, median (IQR), n impaired 8 (6.5-8), 3 8 (4.5-8), 5 0.05 (-1.99) * 8 (5-8), 8 
Working resumption, n (%) 14/17 (82) 2/9 (22) 0.009 ** 16/26 (61) 
Driving resumption, n (%) 24/29 (83) 5/11 (45) 0.04 * 29/40 (73) 
Juan et al.  
All measures were obtained at 6 months follow-up by the same certified neuropsychologist, except CPC 
at 3 months, which was obtained through a phone interview by one research nurse. CPC Cerebral 
Performance Category; GOSE Glasgow Outcome Scale Extended; mRS modified Rankin scale; 
QOLIBRI Quality Of Life after Brain Injury (high percentage means high satisfaction); HAD Hospital 
Anxiety and Depression scale (a score > 11 points indicates the probable presence of the disorder); IADL 
Instrumental Activities of Daily Living (8 points: maximal independence). * p < 0.05; ** p < 0.01.  
§ 49 patients (14/15 patients in the “not returned to pre-injury functioning” group: one patient was unable 
to answer further questions due to severe cognitive impairment).  
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Clinical examination during coma 
 
Methods 
Early clinical variables were prospectively collected in the first days following admission, 
while patients were comatose. Neurological examination testing brainstem reflexes (1), motor 
response and early myoclonus were performed repetitively after rewarming and up to 72h 
after CA. Serum NSE was sampled at 24h and/or 48h after CA and analyzed with an 
automated immunofluorescent assay (BRAHMS Kryptor, Immunodiagnostic Systems, 
Hennigsdorf, Germany); the highest value was selected for this study. Cortical response to 
median-nerve somatosensory evoked potentials (SSEP) was tested once after rewarming, 24h 
to 72h after CA (2). Two video-EEGs recordings (21 electrodes, Viasys Neurocare, Madison, 
WI, USA) were performed, 2-36 hours and 24-72h after CA onset and visually qualified by 
EEG-certified neurologists (3). Here we report only background reactivity to stimuli, since it 
has been robustly related to survival in previous studies (4). Using the same EEG clinical 
montage, most patients were also tested with an auditory discrimination paradigm predicting 
survival (5) and good early cognitive outcome (6). CPC was assessed at 3 months through a 
routine phone interview with patients or caregivers (7). 
 
Results 
All patients but two were treated with mild therapeutic hypothermia to 33-34°C for 24h (8). 
Two patients (4%) had a non-reactive EEG background on Day 1 and none on Day 2; one 
(2%) presented an early myoclonus; six (12%) had at least one brainstem reflex absent at 72 
hours; 13 (26%) had absent motor response and none had bilaterally absent SSEP. Serum 
NSE peak was available in 46 patients (mean: 24 ± 15 µg/ml) with one outlier above 75 
µg/ml (3). Evolution of auditory discrimination was available for a subset of 42 patients and 
Juan et al.  
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showed progression in 18 (43%). On average, patients spent 6 ± 4 days in coma and a total of 
19 ± 16 days in the hospital. Twelve patients (24%) were referred to a specialized 
neurorehabilitation center at discharge. 
In order to assess whether subjective recovery can be predicted from early clinical 
examination, we compared patients reporting complete vs. incomplete recovery on these 
variables. No difference was found on clinical tests, progression of auditory discrimination, or 
coma and hospital duration (see Table 1 below). However, the two groups differed early after 
hospital discharge, since more of the “incomplete recovery” survivors were addressed to 
neurorehabilitation centers. 
 
Discussion 
Early multimodal prognostication during coma did not discriminate survivors with complete 
vs. incomplete recovery, making detailed long-term recovery difficult to predict. Finding 
association between multimodal examination during coma and long-term outcome is 
particularly challenging since acute examination is specific to mortality prediction (4), 
therefore providing very limited information for good outcome. Much fewer tests are 
associated with survival and even less have been shown to delineate the quality of recovery. 
S-100B protein and long-latency SSEP (N70) have been related with memory performances 
and executive functions(9, 10), while recently our group showed that progression of auditory 
discrimination predicted early cognitive and functional outcome (6). As opposed to early 
assessment where outcome variability is large, at 6 months follow-up most recovery has 
happened and the range of neurological impairment is reduced, therefore making it difficult to 
find any predictors. 
 
  
Juan et al.  
 3 
 
Table 1. Results of the clinical tests performed during coma split by subjective recovery 
groups. 
 
Fisher exact test was used for categorical variables (p value reported) and Wilcoxon signed 
rank test for continuous variables (p value and Z value reported). EEG 
electroencephalography, GCS Glasgow Coma Scale, IQR interquartile range, MRI magnetic 
resonance imaging, NSE neuron-specific enolase, ROSC return of spontaneous circulation, 
SSEP somatosensory evoked potential. * p < 0.05. 
a pupillary, oculocephalic, corneal; all present vs. one or more absent 
b flexion posturing or better vs. extension or no response 
c EEG reactivity to repetitive auditory and painful stimulations (categorized as present if clear 
and reproducible change in amplitude or frequency vs. absent) 
 
 
  
Clinical tests Survivors reporting 
satisfactory recovery  
(n = 35) 
Survivors reporting 
unsatisfactory recovery 
(n = 15) 
p value  
(Z value) 
Investigations during coma, n (%)    
Early myoclonus present 1 (3) 0 (0) 1  
Brainstem reflexes absent a 4 (11) 2 (13) 1  
GCS motor response [1-2] b 9 (26) 4 (27) 1 
Cortical SSEP bilaterally absent 0/31 (0) 0/14 (0) 1 
NSE peak, median (IQR), µg/ml 20 (15-29) (n=32)  19 (14-29) (n=14) 0.9 (0.13) 
Non reactive EEG on Day 1 c 1/31 (3) 1/13 (8)  0.5 
Non reactive EEG on Day 2 c 0 (0) 0 (0) 1  
Progression of auditory discrimination  13/29 (45) 5/13 (38) 0.7  
Hospital outcome, median (IQR)    
Coma duration, days 4 (3-7) 5 (3-7) 0.6 (-0.46) 
Hospital stay duration, days 13 (9-21) 19 (15-25)  0.2 (-1.39) 
Neurorehabilitation treatment, n (%) 5 (14) 7 (47)  0.03 *  
Juan et al.  
 4 
References 
 
1.  Rossetti AO, Oddo M, Logroscino G, et al.: Prognostication after cardiac arrest and 
hypothermia: a prospective study. [Internet]. Ann Neurol 2010; 67:301–7[cited 2013 
Mar 1] Available from: http://www.ncbi.nlm.nih.gov/pubmed/20373341 
2.  Oddo M, Rossetti AO: Early multimodal outcome prediction after cardiac arrest in 
patients treated with hypothermia. [Internet]. Crit Care Med 2014; 42:1340–7[cited 
2014 Jul 17] Available from: http://www.ncbi.nlm.nih.gov/pubmed/24463859 
3.  Rossetti AO, Tovar Quiroga DF, Juan E, et al.: Electroencephalography Predicts Poor 
and Good Outcomes After Cardiac Arrest [Internet]. Crit Care Med 2017; 1[cited 2017 
May 1] Available from: http://www.ncbi.nlm.nih.gov/pubmed/28406812 
4.  Rossetti AO, Rabinstein AA, Oddo M: Neurological prognostication of outcome in 
patients in coma after cardiac arrest [Internet]. Lancet Neurol 2016; 15:597–
609Available from: http://linkinghub.elsevier.com/retrieve/pii/S1474442216000156 
5.  Tzovara A, Rossetti AO, Juan E, et al.: Prediction of awakening from hypothermic 
postanoxic coma based on auditory discrimination. Ann Neurol 2016; 79:748–757 
6.  Juan E, De Lucia M, Tzovara A, et al.: Prediction of cognitive outcome based on the 
progression of auditory discrimination during coma. Resuscitation 2016; 106:89–95 
7.  Booth CM, Boone RH, Tomlinson G, et al.: Is This Patient Dead , Vegetative , or 
Severely Neurologically Impaired ? Assessing Outcome for Comatose Survivors of 
Cardiac Arrest [Internet]. J Am Med Assoc 2004; 291:870–879Available from: 
http://www.ncbi.nlm.nih.gov/pubmed/14970067 
8.  Oddo M, Schaller M-D, Feihl F, et al.: From evidence to clinical practice: Effective 
implementation of therapeutic hypothermia to improve patient outcome after cardiac 
arrest [Internet]. Crit Care Med 2006; 34:1865–73[cited 2013 Nov 5] Available from: 
Juan et al.  
 5 
http://www.ncbi.nlm.nih.gov/pubmed/16715035 
9.  Prohl J, Röther J, Kluge S, et al.: Prediction of short-term and long-term outcomes after 
cardiac arrest: a prospective multivariate approach combining biochemical, clinical, 
electrophysiological, and neuropsychological investigations. [Internet]. Crit Care Med 
2007; 35:1230–7[cited 2013 Mar 4] Available from: 
http://www.ncbi.nlm.nih.gov/pubmed/17414735 
10.  Prohl J, Bodenburg S, Rustenbach SJ: Early prediction of long-term cognitive 
impairment after cardiac arrest. [Internet]. J Int Neuropsychol Soc 2009; 15:344–
53[cited 2013 Mar 20] Available from: 
http://www.ncbi.nlm.nih.gov/pubmed/19402920 
 
 
 
Juan et al. 
 1 
 
Table 2. Long-term cognitive results by subjective recovery group.  
Cognitive test Survivors reporting  
satisfactory recovery  
(n = 30) 
Survivors reporting 
unsatisfactory recovery  
(n = 12) 
p value  
(Z value) 
Total impaired, 
n (%) 
 Raw scores 
(n impaired) 
Z scores 
(n impaired) 
Raw scores 
(n impaired) 
Z scores  
(n impaired) 
  
Language       
Naming a N/A -0.47 ± 1.52 (7) N/A -1.17 ± 2.1 (2) 0.3 (1.03) 9 (21) 
Metaphor interpretation § 35 ± 3 -0.37 ± 1 (5) 34 ± 2.5 -0.72 ± 1.66 (2) 0.7 (-0.42) 7/25 (28) 
Gnosia       
Figures recognition  15 ± 0.4 (2) N/A 15 ± 0 (0) N/A 0.4 (0.87) 2 (5) 
Celebrities identification  7.8 ± 0.5 (1) N/A 7.7 ± 0.7 (1) N/A 0.4 (-0.9) 2 (5) 
Praxia       
Constructive praxia 10.7 ± 0.6 0.49 ± 0.63 (0) 10.5 ± 0.7 0.47 ± 0.47 (0) 0.5 (0.64) 0 (0) 
Gestual praxia  12 ± 0.4 (0) N/A 12 ± 0.3 (0) N/A 0.4 (0.88) 0 (0) 
Short-term / working verbal 
memory 
      
Digit span forward (nb) 8 ± 2 -0.17 ± 0.95 (1) 8 ± 2 -0.33 ± 0.72 (1) 0.8 (0.24) 2 (5) 
Digit span backward (nb) 8 ± 2 -0.03 ± 0.81 (0) 7 ± 2 -0.30 ± 0.75 (1) 0.4 (0.8) 1 (2) 
Digit span reorganization (nb) 8 ± 2 0.13 ± 0.92 (0) 7 ± 2 -0.33 ± 0.91 (1) 0.3 (0.98) 1 (2) 
Short-term / working visual 
memory  
      
Visual span forward (nb) 9 ± 2 0.33 ± 1.06 (1) 7 ± 2 -0.64 ± 0.98 (3) 0.02 (2.41) * 4 (10) 
Visual span backward (nb) 7 ± 2 0.15 ± 0.75 (1) 6 ± 2 -0.28 ± 0.93 (0) 0.09 (1.66) 1 (2) 
Long-term verbal memory       
CVLT learning 55 ± 13 0.36 ± 1.25 (4) 47 ± 14 -0.9 ± 1.49 (2) 0.009 (2.6) ** 6 (14) 
CVLT long-term free recall 12 ± 4 0.15 ± 1.2 (2) 8 ± 4 -1.48 ± 1.66 (6) 0.003 (2.92) ** 8 (19) 
Long-term visual memory       
Doors A (n correct) 11 ± 1 0.35 ± 1.06 (1) 9 ± 2 -1.22 ± 1.07 (6) <0.001 (3.5) ** 7 (17) 
Doors B (n correct) 8 ± 3 0.31 ± 1.19 (2) 7 ± 2 -0.6 ± 0.83 (1) 0.02 (2.27) * 3 (7) 
Executive functions       
Phonemic verbal fluency (n) 18 ± 7 -0.33 ± 1.06 (3) 17 ± 6 -0.45 ± 1.18 (3) 0.7 (0.39) 6 (14) 
Semantic verbal fluency (n) 25 ± 7 -0.48 ± 0.82 (4) 24 ± 6 -0.82 ± 0.95 (2) 0.4 (0.84) 6 (14) 
Generation N/A -0.41 ± 0.84 (1) N/A -0.64 ± 0.91 (2) 0.48 (0.71) 3 (7) 
Trail Making test A (s) 43 ± 22 0.3 ± 0.58 (0) 46 ± 10 -0.07 ± 0.59 (0) 0.07 (1.82) 0 (0) 
Trail Making test B (s) 116 ± 71 0.12 ± 0.81 (1) 121 ± 52 -0.38 ± 1.01 (2) 0.2 (1.36) 3 (7) 
Trail Making test B-A (s) 73 ± 53 -0.04 ± 0.84 (1) 75 ± 54 -0.45 ± 1.15 (3) 0.4 (0.93) 4 (10) 
Stroop naming (s) 75 ± 20 -0.59 ± 1.18 (4) 94 ± 40 -1.91 ± 2.3 (6) 0.05 (1.92) 10 (24) 
Juan et al. 
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Stroop reading (s) 49 ± 9 -0.52 ± 1.14 (6) 59 ± 14 -1.64 ± 1.65 (6) 0.04 (2.06) * 12 (29) 
Stroop interference (s) 151 ± 59 -0.65 ± 1.58 (4) 164 ± 54 -1.27 ± 1.8 (4) 0.2 (1.21) 8 (19) 
Inhibition  76 ± 45 -0.56 ± 1.52 (5) 69 ± 47 -0.36 ± 1.78 (2) 0.6 (-0.49) 7 (17) 
Initiation N/A -0.27 ± 0.85 (2) N/A -1.21 ± 1.29 (6) 0.03 (2.19) * 8 (19) 
Productivity (n) 27 ± 11 -0.23 ± 1.06 (2) 24 ± 8 -0.55 ± 0.88 (1) 0.5 (0.63) 3 (7) 
FAB total  16 ± 2 (5) N/A 16 ± 2 (2) N/A 0.6 (0.59) 7 (17) 
Attention       
Symbol-digit subtest, n 49 ± 16 -0.59 ± 0.85 (5) 42 ± 14 -1.25 ± 0.88 (4) 0.03 (2.14) * 9 (21) 
TAP reactivity: no signal, ms § 263 ± 51 -0.41 ± 0.94 (1) 290 ± 95  -0.65 ± 0.97 (1) 0.6 (-0.53) 2 (5) 
TAP reactivity: signal, ms § 260 ± 43 -0.62 ± 0.75 (2) 279 ± 91  -0.66 ± 0.95 (1) 0.8 (-0.21) 3(7) 
TAP div. attention: auditive, ms § 649 ± 113 -0.92 ± 1.01 (6) 653 ± 162  -0.88 ± 1.06 (3) 0.9 (0.09) 9 (21) 
TAP div. attention: visual, ms § 881 ± 168 -0.19 ± 1.04 (2) 993 ± 224  -0.86 ± 0.91 (2) 0.05 (-1.96) * 4 (10) 
TAP div. attention: omissions, n § 3.6 ± 3.7 -0.64 ± 0.99 (5) 5.9 ± 3.8 -1.38 ± 1 (7) 0.02 (-2.25) * 12 (29) 
GCI index, n 1.2 ± 1.8 (4) N/A 2.8 ± 1.5 (7) N/A 0.001 (-3.21) ** 11 (26) 
Raw scores (mean ± std), z scores (mean ± std) and number of patients impaired (n), p value (Z value) of Wilcoxon signed 
rank test. A given test was considered as impaired when z score <= -1.65 std, or according to each test’s provided cut-off 
when no z score was available (i.e. FAB < 15/18; Figures recognition < 15/15; Celebrities identification < 7/8; Gestual 
praxia < 9/12). Statistics were performed on normalized z scores or on raw scores when z scores not available. CVLT 
California Verbal Learning Task, FAB Frontal Assessment Battery, GCI global cognitive impairment (number of 
cognitive domains impaired from the reduced battery, max = 13), TAP Test of Attentional Performance. * p < 0.05; ** p < 
0.01. Scores in italic are displayed in Fig. 2.  
 
§  Not all patients performed these tests: ‘Metaphor recognition’: 25/30 patients in the “complete recovery” group, 8/12 in 
the “incomplete recovery” group (test was included late to the protocol); ‘TAP reactivity’: 29/30 patients in the “complete 
recovery” group (one patient was tested at home with no TAP available); ‘TAP divided attention’: 28/30 patients in the 
“complete recovery” group (one patient was tested at home with no TAP available and one was unable to perform the test 
even after several training trials). 
a Raw scores not presented because two versions were used depending on patient’s age ( < 60 years: standard version with 
80 items; > 60 years: reduced version with 64 items).  
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Scores description 
 
Language 
•  Naming subtest, Lexis battery [1]. 
•  Metaphor interpretation subtest, Protocole Montréal d’Evaluation de la Communication (MEC) 
[2].  
Gnosia 
• Figure recognition subtest, Batterie d’Evaluation de la Négligence unilatérale (BEN) [3]. 
• Celebrities identification (home test consisting in identification and denomination of eight 
famous national and international personalities). 
Praxia 
• Constructive praxia, Praxis subtest, CERAD battery [4]. 
• Gestual praxia, Apraxia Screen of TULIA (AST) [5]. 
Short-term and working verbal memory 
• Digit span forward, French version of the Wechsler Adult Intelligence Scale, fourth edition 
(WAIS-IV) [6]. 
• Digit span backward, French version of the Wechsler Adult Intelligence Scale, fourth edition 
(WAIS-IV) [6]. 
• Digit span ascending, French version of the Wechsler Adult Intelligence Scale, fourth edition 
(WAIS-IV) [6].  
Short-term and working visual memory 
• Block tapping forward, French version of the Wechsler Memory Scale, third edition (MEM III) 
[7].  
• Block tapping backward, French version of the Wechsler Memory Scale, third edition (MEM 
III) [7].   
Long-term verbal memory 
• Learning score, French version of the California Verbal Learning Test (CVLT) [8]. 
• Long-term free recall score, French version of the California Verbal Learning Test (CVLT) [8]. 
Long-term visual memory 
• Doors A subtest, Doors and People test [9].  
• Doors B subtest, Doors and People test [9].  
Juan et al. 
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Executive functions 
• Semantic verbal fluency (GREFEX battery) [10]. 
• Phonemic verbal fluency (GREFEX battery) [10]. 
o Generation: average z scores of semantic and phonemic verbal fluency  
• Trail Making Test (GREFEX battery) [10]. 
• Stroop test (GREFEX battery) [10]. 
o Initiation: average z scores of Trail Making Test part A, Stroop reading and Stroop 
naming 
o Inhibition: subtraction of Stroop interference from Stroop naming times 
• Productivity score, Five-points test [11]. 
• Frontal Assessment Battery (FAB) [12]. 
Attention 
• Digit-symbol subtest, French version of the Wechsler Adult Intelligence Scale, fourth edition 
(WAIS-IV) [6].  
• Alert subtest, Test battery for Attentional Performance (TAP) [13]. 
• Divided Attention subtest, Test battery for Attentional Performance (TAP) [13]. 
 
Global cognitive impairment index 
• Individual number of tests impaired for each patient on the 13 cognitive domains (tests in 
italics). 
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